Pharma supply chains

Roche chair compares US tariff policy to ‘blackmail’

Schwan identified protectionism by the United ‌States and China as the firm's biggest geopolitical worry.

This content was published on Jun 5, 2026 Roche chair slams US tariffs as “blackmail" and warns rising US-China protectionism is top geopolitical risk.

Sandoz on the offensive against Chinese antibiotics on sale

Drug pricing

Swiss drugmaker complains of Chinese antibiotics dumping

This content was published on May 28, 2026 Sandoz steps up criticism of imports of low-priced antibiotics from China.

Swissmedic is monitoring the Tavmeos drug situation

Patient safety

Switzerland monitors Japanese concerns over Tavneos drug

This content was published on May 19, 2026 Swissmedic closely monitoring international developments around the drug Tavneos.

Tampax tampon products on a supermarket shelf

Pharma supply chains

Major Swiss retailers face tampons shortage amid price negotiations

This content was published on May 9, 2026 Feminine hygiene products have been disappearing from Swiss supermarket shelves, as several retailers negotiate prices with American giant Procter & Gamble.

Novartis closes plant in Germany, 220 jobs away

Workplace

Novartis to close site in Germany and cut 220 jobs

This content was published on May 6, 2026 Swiss drugmaker Novartis plans to cut around 220 jobs in Germany as part of the planned closure of a production site in Wehr ⁠by the end of 2028.

Novartis opens seventh plant in the United States

New treatments

Swiss pharma firm Novartis plans seventh US plant

This content was published on Apr 30, 2026 Novartis is expanding its production capacity in the United States, with the announcement of a new site in Morrisville, North Carolina. This plant will bring to seven the number of new sites planned as part of its $23 billion investment plan.

Pharma supply chains

From Covid to Hormuz, what has Switzerland learned about drug shortages?

This content was published on Apr 23, 2026 While immediate drug shortages aren't expected, experts say the Middle East conflict could impact medicine availability in Switzerland.

Full transparency from the FOPH on Covid-19 vaccines

Drug pricing

Swiss court forces Covid vaccine procurement transparency

This content was published on Apr 16, 2026 Court forces Switzerland to release unredacted Covid vaccine contracts from the pandemic.

A supercomputer is being powered on during a photo op.

AI and medicine

Explainer: why Roche’s supercomputer is a big deal

This content was published on Mar 26, 2026 Pharma companies are racing to acquire microchips and achieve the most powerful AI capacity in the industry. But drug development is tricky and AI talents scarce.

Pharma supply chains

Lonza sells off its capsules division to British firm

This content was published on Mar 7, 2026 The Swiss firm is selling its capsules and health ingredients business to Lone Star Funds for CHF2.3 billion ($3 billion).

Pharma supply chains

Popular Stories

Most Discussed

Sign in and personalize Swissinfo

Pharma supply chains

More

Roche chair compares US tariff policy to ‘blackmail’

More

Swiss drugmaker complains of Chinese antibiotics dumping

More

Switzerland monitors Japanese concerns over Tavneos drug

More

Major Swiss retailers face tampons shortage amid price negotiations

More

Novartis to close site in Germany and cut 220 jobs

More

Swiss pharma firm Novartis plans seventh US plant

More

From Covid to Hormuz, what has Switzerland learned about drug shortages?

More

Swiss court forces Covid vaccine procurement transparency

More

Explainer: why Roche’s supercomputer is a big deal

More

Lonza sells off its capsules division to British firm

Popular Stories

Most Discussed